Stay updated on Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2F037Dd7oFwe12-M2wItGX0y6PA7Q.uncropped.jpg&w=3840&q=75)
Latest updates to the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has been updated to version v2.10.0, with three locations now included, replacing the previous version v2.9.7.SummaryDifference0.3%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check16 days agoChange DetectedDifference0.3%
- Check17 days agoChange DetectedDifference0.2%
- Check24 days agoChange DetectedThe value 'Ovarian Epithelial Cancer Fallopian Tube Cancer' has been updated to 'Fallopian Tube Cancer Ovarian Epithelial Cancer'. This change represents a reversal in the order of the types of cancer mentioned on the webpage.SummaryDifference0.3%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.